Asphalt Tile (G-I Holdings)

Asphalt floor tile manufactured by G-I Holdings contained chrysotile asbestos and was produced from 1959 through 1971. Workers who installed, maintained, or disturbed this flooring material during its production years and in the decades that followed faced potential exposure to airborne asbestos fibers. Litigation records document claims arising from occupational contact with this product across a range of industrial settings.

Product Description

Asphalt tile was one of the most widely used resilient flooring materials in the mid-twentieth century. Durable, inexpensive, and relatively easy to install, it was favored for commercial, industrial, and institutional applications throughout the postwar building boom. The tiles were typically manufactured in nine-inch or twelve-inch squares and were bonded to subfloors using adhesive compounds, many of which also contained asbestos during this era.

G-I Holdings — a corporate successor entity with roots in the building materials industry — produced asphalt tile bearing chrysotile asbestos from 1959 through 1971. The product was marketed to construction trades and building supply distributors serving the industrial and commercial sectors. Like many flooring products of the period, the tile’s asbestos content was not prominently disclosed to the workers who routinely handled it.

Asbestos Content

The asbestos incorporated into G-I Holdings asphalt tile was chrysotile, sometimes called “white asbestos.” Chrysotile is the most commercially prevalent form of asbestos and accounts for the vast majority of asbestos used in building products throughout the twentieth century. It was valued by flooring manufacturers for several properties: it reinforced the structural integrity of the tile matrix, improved resistance to cracking under load, and helped the finished product withstand temperature fluctuations common in industrial environments.

Although chrysotile fibers are often described as relatively less potent than amphibole asbestos varieties such as crocidolite or amosite, no form of asbestos has been established as safe at occupational exposure levels. Regulatory frameworks including the Occupational Safety and Health Administration (OSHA) asbestos standards and the Asbestos Hazard Emergency Response Act (AHERA) treat chrysotile as a regulated hazardous substance subject to strict handling, abatement, and disposal requirements.

In asphalt tile, chrysotile fibers were bound within the tile matrix during normal, undisturbed conditions. However, the binding characteristics of older asphalt-based products degrade over time, and mechanical disturbance — cutting, grinding, sanding, breaking, or demolition — could release respirable fibers into the surrounding air.

How Workers Were Exposed

Litigation records document that industrial workers were among those most commonly exposed to asbestos-containing asphalt tile manufactured by G-I Holdings. Exposure pathways in industrial environments were often more intensive than in residential or light commercial settings, owing to the scale of flooring installations, the frequency of maintenance and repair cycles, and the physical demands of industrial floor use.

Workers in manufacturing plants, warehouses, power generation facilities, shipyards, and similar heavy-industry environments encountered asphalt tile in several ways. Installers cut tiles to fit using saws, scoring tools, or snapping techniques that generated dust. Those performing repairs broke up and removed existing tile — a process that, when conducted on older, brittle asphalt tile, plaintiffs alleged released significant concentrations of chrysotile fibers. Maintenance workers who buffed, sanded, or refinished industrial floors without adequate respiratory protection similarly faced potential fiber inhalation.

Plaintiffs alleged that in many industrial settings, asphalt tile disturbance occurred without adequate ventilation controls, without the provision of appropriate respiratory protective equipment, and without any warning that the flooring material contained asbestos. Workers in adjacent areas were also exposed, as fiber-laden dust generated during flooring work could migrate through open industrial floor plans.

Asbestos-related diseases linked to chrysotile exposure include mesothelioma, lung cancer, asbestosis, and other pulmonary conditions. These diseases are characterized by long latency periods, often ranging from ten to fifty years between initial exposure and clinical diagnosis. As a result, workers exposed to G-I Holdings asphalt tile during its production years between 1959 and 1971 may have first received diagnoses many decades after their occupational contact with the product.

Litigation records document that plaintiffs alleged G-I Holdings and its corporate predecessors knew or had reason to know of the hazards associated with asbestos in their flooring products during the years of manufacture, yet failed to adequately warn workers of those risks.

G-I Holdings does not have an active asbestos bankruptcy trust fund associated with this product. Claims arising from exposure to G-I Holdings asphalt tile are therefore pursued through civil litigation in state and federal courts rather than through a trust claim process.

Civil Litigation Pathway

Litigation records document that individuals diagnosed with mesothelioma, lung cancer, asbestosis, or related asbestos diseases following occupational contact with G-I Holdings asphalt tile have filed personal injury lawsuits against the company and its corporate successors. Plaintiffs alleged product liability on theories including failure to warn, negligent design, and breach of implied warranty of merchantability.

Surviving family members of workers who died from asbestos-related disease have pursued wrongful death claims under similar theories. Litigation records document that plaintiffs in these cases presented evidence of occupational exposure history, medical diagnosis, and corporate knowledge of asbestos hazards during the relevant production period.

Steps for Affected Workers and Families

Individuals who worked with or around G-I Holdings asphalt tile between 1959 and 1971 — or who worked in facilities where this tile was later disturbed during renovation or demolition — and who have received a diagnosis of an asbestos-related disease should consider the following steps:

  • Document exposure history. Gather employment records, union records, co-worker statements, or other documentation establishing contact with the product.
  • Obtain a confirmed medical diagnosis. A pathological or clinical diagnosis of an asbestos-related condition is foundational to any legal claim.
  • Consult an asbestos litigation attorney. Because this product’s claims proceed through litigation rather than a trust fund, legal representation is essential to evaluating the appropriate defendants, jurisdiction, and litigation strategy.
  • Act within applicable statutes of limitations. Deadlines for filing asbestos claims vary by state and are typically measured from the date of diagnosis or the date the claimant knew or should have known of the asbestos connection to their illness. These deadlines are strictly enforced.

Asbestos litigation is a specialized field with established procedures for proving exposure, causation, and damages. Workers and families affected by G-I Holdings asphalt tile should seek counsel experienced in occupational asbestos cases to evaluate all available legal remedies.